Company intelligence / Profile preview
LayerBio
Medford, Massachusetts, United Stateslayerbio.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
01
Overview
LayerBio’s lead product OcuRing™ delivers drugs via a bioerodible ring placed on intraocular lenses during cataract surgery to prevent complications such as inflammation. The company has received significant non-dilutive funding from the NIH, NSF, and DoD to advance its clinical programs. Lead assets include formulations of corticosteroids and NSAIDs for ophthalmic use. Clinical results are not yet published.
- Therapeutic areas
- OtherOphthalmology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Sponsored research collaborations with industry partnersU.S. Department of Defense grant supportNIH/NSF SBIR grants
Beyond the preview
Go deeper on LayerBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LayerBio.